Generation of the First Structure-Based Pharmacophore Model Containing a Selective “Zinc Binding Group” Feature to Identify Potential Glyoxalase-1 Inhibitors
Open Access
- 22 November 2012
- Vol. 17 (12) , 13740-13758
Abstract
Within this study, a unique 3D structure-based pharmacophore model of the enzyme glyoxalase-1 (Glo-1) has been revealed. Glo-1 is considered a zinc metalloenzyme in which the inhibitor binding with zinc atom at the active site is crucial. To our knowledge, this is the first pharmacophore model that has a selective feature for a “zinc binding group” which has been customized within the structure-based pharmacophore model of Glo-1 to extract ligands that possess functional groups able to bind zinc atom solely from database screening. In addition, an extensive 2D similarity search using three diverse similarity techniques (Tanimoto, Dice, Cosine) has been performed over the commercially available “Zinc Clean Drug-Like Database” that contains around 10 million compounds to help find suitable inhibitors for this enzyme based on known inhibitors from the literature. The resultant hits were mapped over the structure based pharmacophore and the successful hits were further docked using three docking programs with different pose fitting and scoring techniques (GOLD, LibDock, CDOCKER). Nine candidates were suggested to be novel Glo-1 inhibitors containing the “zinc binding group” with the highest consensus scoring from docking.Keywords
This publication has 48 references indexed in Scilit:
- ZINC: A Free Tool to Discover Chemistry for BiologyJournal of Chemical Information and Modeling, 2012
- Tautomer Preference in PDB Complexes and its Impact on Structure-Based Drug DiscoveryJournal of Chemical Information and Modeling, 2010
- Let’s not forget tautomersJournal of Computer-Aided Molecular Design, 2009
- Inhibition of Glyoxalase I: The First Low-Nanomolar Tight-Binding InhibitorsJournal of Medicinal Chemistry, 2009
- Molecular similarity analysis in virtual screening: foundations, limitations and novel approachesDrug Discovery Today, 2007
- Similarity-based virtual screening using 2D fingerprintsDrug Discovery Today, 2006
- Molecular similarity: a key technique in molecular informaticsOrganic & Biomolecular Chemistry, 2004
- Glyoxalase I – structure, function and a critical role in the enzymatic defence against glycationBiochemical Society Transactions, 2003
- Improved protein–ligand docking using GOLDProteins: Structure, Function, and Bioinformatics, 2003
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997